Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.670 million estimate.
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29...
B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target...
Biote (NASDAQ:BTMD) lowers FY2025 sales outlook from $202.000 million-$208.000 million to $190.000 million vs $204.667 million ...
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 58.73 ...
